{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:45:45Z","timestamp":1769633145564,"version":"3.49.0"},"reference-count":24,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Open Access Publication Fund of University of M\u00fcnster","award":["CRC 1450\u2014431460824"],"award-info":[{"award-number":["CRC 1450\u2014431460824"]}]},{"name":"Deutsche Forschungsgemeinschaft","award":["CRC 1450\u2014431460824"],"award-info":[{"award-number":["CRC 1450\u2014431460824"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Post-transplant diabetes mellitus (PTDM) after kidney transplantation induced by tacrolimus is an important issue. Fast tacrolimus metabolism, which can be estimated by concentration-to-dose (C\/D) ratio, is associated with increased nephrotoxicity and unfavorable outcomes after kidney transplantation. Herein, we elucidate whether fast tacrolimus metabolism also increases the risk for PTDM. Data from 596 non-diabetic patients treated with tacrolimus-based immunosuppression at the time of kidney transplantation between 2007 and 2015 were retrospectively analyzed. The median follow-up time after kidney transplantation was 4.7 years (IQR 4.2 years). Our analysis was complemented by experimental modeling of fast and slow tacrolimus metabolism kinetics in cultured insulin-producing pancreatic cells (INS-1 cells). During the follow-up period, 117 (19.6%) patients developed PTDM. Of all patients, 210 (35.2%) were classified as fast metabolizers (C\/D ratio &lt; 1.05 ng\/mL \u00d7 1\/mg). Fast tacrolimus metabolizers did not have a higher incidence of PTDM than slow tacrolimus metabolizers (p = 0.496). Consistent with this, insulin secretion and the viability of tacrolimus-treated INS-1 cells exposed to 12 h of tacrolimus concentrations analogous to the serum profiles of fast or slow tacrolimus metabolizers or to continuous exposure did not differ (p = 0.286). In conclusion, fast tacrolimus metabolism is not associated with increased incidence of PTDM after kidney transplantation, either in vitro or in vivo. A short period of incubation of INS-1 cells with tacrolimus using different concentration profiles led to comparable effects on cell viability and insulin secretion in vitro. Consistent with this, in our patient, collective fast Tac metabolizers did not show a higher PTDM incidence compared to slow metabolizers.<\/jats:p>","DOI":"10.3390\/ijms23169131","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T20:58:08Z","timestamp":1660597088000},"page":"9131","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fast Tacrolimus Metabolism Does Not Promote Post-Transplant Diabetes Mellitus after Kidney Transplantation"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1136-438X","authenticated-orcid":false,"given":"Ulrich","family":"Jehn","sequence":"first","affiliation":[{"name":"Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of Muenster, 48149 Muenster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Wiedmer","sequence":"additional","affiliation":[{"name":"Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of Muenster, 48149 Muenster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran Ramin","family":"Boeckel","sequence":"additional","affiliation":[{"name":"Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of Muenster, 48149 Muenster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Pavenst\u00e4dt","sequence":"additional","affiliation":[{"name":"Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of Muenster, 48149 Muenster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3180-6245","authenticated-orcid":false,"given":"Gerold","family":"Th\u00f6lking","sequence":"additional","affiliation":[{"name":"Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of Muenster, 48149 Muenster, Germany"},{"name":"Department of Internal Medicine and Nephrology, University Hospital of M\u00fcnster Marienhospital Steinfurt, 48565 Steinfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Reuter","sequence":"additional","affiliation":[{"name":"Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of Muenster, 48149 Muenster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00007691-199512000-00007","article-title":"Mode of action of tacrolimus (FK506): Molecular and cellular mechanisms","volume":"17","author":"Thomson","year":"1995","journal-title":"Ther. Drug Monit."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"(2009). KDIGO clinical practice guideline for the care of kidney transplant recipients. Am. J. Transplant., 9, S1\u2013S155.","DOI":"10.1111\/j.1600-6143.2009.02834.x"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/1389200219666180101104159","article-title":"Tacrolimus\u2014Pharmacokinetic Considerations for Clinicians","volume":"19","author":"Tholking","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Sch\u00fctte-N\u00fctgen, K., Th\u00f6lking, G., Steinke, J., Pavenst\u00e4dt, H., Schmidt, R., Suwelack, B., and Reuter, S. (2019). Fast Tac Metabolizers at Risk\u2014It is Time for a C\/D Ratio Calculation. J. Clin. Med., 8.","DOI":"10.3390\/jcm8050587"},{"key":"ref_5","first-page":"S163","article-title":"The tacrolimus metabolism affect post-transplant outcome mediating acute rejection and delayed graft function: Analysis from Korean Organ Transplantation Registry data","volume":"34","author":"Ro","year":"2021","journal-title":"Transpl. Int. Off. J. Eur. Soc. Organ Transplant."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Thongprayoon, C., Hansrivijit, P., Kovvuru, K., Kanduri, S.R., Bathini, T., Pivovarova, A., Smith, J.R., and Cheungpasitporn, W. (2020). Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant Recipients. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072193"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1111\/ajt.15483","article-title":"Inhibition of the mTOR pathway: A new mechanism of \u03b2 cell toxicity induced by tacrolimus","volume":"19","author":"Rovira","year":"2019","journal-title":"Am. J. Transplant."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000514288","article-title":"Post-Transplant Diabetes Mellitus and Prediabetes in Renal Transplant Recipients: An Update","volume":"145","author":"Porrini","year":"2021","journal-title":"Nephron"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1097\/00007890-199506000-00018","article-title":"Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell","volume":"59","author":"Tamura","year":"1995","journal-title":"Transplantation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"12297","DOI":"10.3892\/mmr.2021.12297","article-title":"Tacrolimus inhibits insulin release and promotes apoptosis of Min6 cells through the inhibition of the PI3K\/Akt\/mTOR pathway","volume":"24","author":"Tong","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/07435800.2015.1094088","article-title":"Hypomagnesemia linked to new-onset diabetes mellitus after kidney transplantation: A systematic review and meta-analysis","volume":"41","author":"Cheungpasitporn","year":"2016","journal-title":"Endocr. Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rodriguez-Rodriguez, A.E., Porrini, E., and Torres, A. (2021). Beta-Cell Dysfunction Induced by Tacrolimus: A Way to Explain Type 2 Diabetes?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910311"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ackd.2019.08.006","article-title":"The Many Faces of Calcineurin Inhibitor Toxicity-What the FK?","volume":"27","author":"Farouk","year":"2020","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Th\u00f6lking, G., Sch\u00fctte-N\u00fctgen, K., Schmitz, J., Rovas, A., Dahmen, M., Bautz, J., Jehn, U., Pavenst\u00e4dt, H., Heitplatz, B., and van Marck, V. (2019). A Low Tacrolimus Concentration\/Dose Ratio Increases the Risk for the Development of Acute Calcineurin Inhibitor-Induced Nephrotoxicity. J. Clin. Med., 8.","DOI":"10.3390\/jcm8101586"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1681\/ASN.V131221","article-title":"Glucose metabolism in renal transplant recipients on tacrolimus: The effect of steroid withdrawal and tacrolimus trough level reduction","volume":"13","author":"Boots","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1399-0012.1997.tb00812.x","article-title":"Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients","volume":"11","author":"Katari","year":"1997","journal-title":"Clin. Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature05097","article-title":"Calcineurin\/NFAT signalling regulates pancreatic beta-cell growth and function","volume":"443","author":"Heit","year":"2006","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/ajt.12236","article-title":"The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats","volume":"13","author":"Porrini","year":"2013","journal-title":"Am. J. Transplant."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1111\/ajt.14323","article-title":"Deciphering Tacrolimus-Induced Toxicity in Pancreatic \u03b2 Cells","volume":"17","author":"Wagner","year":"2017","journal-title":"Am. J. Transplant."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States","volume":"3","author":"Kasiske","year":"2003","journal-title":"Am. J. Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15606","DOI":"10.1038\/s41598-021-95201-5","article-title":"Increased renal function decline in fast metabolizers using extended-release tacrolimus after kidney transplantation","volume":"11","author":"Filensky","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1210\/js.2018-00227","article-title":"Hyperglycemia in the Posttransplant Period: NODAT vs Posttransplant Diabetes Mellitus","volume":"2","author":"Gupta","year":"2018","journal-title":"J. Endocr. Soc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/diabetes.49.3.424","article-title":"Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion","volume":"49","author":"Hohmeier","year":"2000","journal-title":"Diabetes"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/16\/9131\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:08:45Z","timestamp":1760141325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/16\/9131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":24,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["ijms23169131"],"URL":"https:\/\/doi.org\/10.3390\/ijms23169131","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]}}}